(Total Views: 705)
Posted On: 07/08/2022 1:11:26 PM
Post# of 148902
Leronlimab, mAb to CCR5, Trims Liver Fat in 14-Week Trial of NASH Patients
https://www.natap.org/2022/EASL/EASL_70.htm?f...dNs1vCqMKg
https://www.natap.org/2022/EASL/EASL_70.htm?f...dNs1vCqMKg
(23)
(0)Scroll down for more posts ▼
